Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
Paricalcitol Improves Anemia of Inflammation

Anemia of inflammation (AI) is a common comorbidity in hemodialysis patients. Paricalcitol is a selective vitamin D receptor activator with potential benefits on anti-inflammatory cytokines expression. The paricalcitol for the secondary hyperparathyroidism control may improve AI decreasing erythropoietin stimulating agents (ESAs) dosage.

vitamin d
transferrin saturation
anemia
vitamins
calcium
  • 30 views
  • 13 Mar, 2021
  • 1 location
Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support

Ferumoxytol injection (Feraheme) is a parenteral form of iron supplementation that is FDA-approved for treatment of iron deficiency anemia. Ferumoxytol injection achieves iron repletion in fewer doses (2) when compared with other available injectable iron formulations (5-6) available at NYU Langone Health, and thus may be useful to reduce travel …

transferrin
iron deficiency anemia
malnutrition
iron
serum ferritin level
  • 0 views
  • 24 Jan, 2021
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

ATG based conditioning regimen in HLA related allogeneic hematopoietic stem cell transplantation for aggressive T-cell tumors: multi-center, open, randomized controlled clinical study

  • 0 views
  • 21 Jan, 2021
  • 1 location
Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients

Studies have shown that hip fractures have a significant perioperative blood loss. Postoperative anaemia is associated with a higher morbidity and mortality. Tranexamic acid is a safe and effective antifibrinolytic widely used to reduce blood loss in other forms of orthopaedic surgery and in traumatized patients. However, evidence on the …

blood transfusion
  • 0 views
  • 27 Jun, 2021
  • 2 locations
Tacrolimus Treatment for Refractory Autoimmune Cytopenia

Autoimmune cytopenia, including autoimmune hemolytic anemia (AIHA), pure red cell aplasia (PRCA), Evans syndrome (ES), usually has good responses to steroids therapies as first line, but there is a considerable percentage of patients who relapse, become refractory or dependent on steroids to maintain an acceptable level of hemoglobin or platelets. …

  • 0 views
  • 23 Jan, 2021
  • 1 location
ILTHPI - Comparison of Medicament Containing Tetracycline Metronidazole Bismuth Versus Amoxicillin Metronidazole Clarithromycin

, peptic ulcer disease, gastric cancer and gastric lymphoma. Endoscopic examination is indicated to confirm the above diagnosis for patient with H. pylori infection. The eradication rate of standard triple

  • 0 views
  • 30 Apr, 2021
  • 1 location
Lithium As a Treatment to Prevent Impairment of Cognition in Elders

Alzheimer's disease (AD) is the most common cause of dementia in adults 65 years and older. AD leads to a complete loss of memory and independent function, and presently there is no cure. Many studies suggest that lithium treatment may delay dementia onset or slow its progression. However, more research …

dementia
demented
memory loss
alzheimer's disease
  • 0 views
  • 18 Jul, 2021
  • 1 location
Assessment of the eFficacy the Onset-of-Action and the Safety of Tot'h ma in Adults With Moderate Iron Deficiency Anaemia

The aim of this study is to assess, in patients with moderate IDA, the Onset-of-Action of a daily treatment with Tot'Hma. The onset of action is defined as the time required for a mean increase of at least 0,5g/dL from baseline in the haemoglobin level.

malaria
renal failure
iron
HIV Infection
anemia
  • 0 views
  • 30 May, 2021
  • 1 location
Treatment of Good Prognosis BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

The purpose of this study is to determine whether a specific subtype of lymphoma responds optimally to treatment with rituximab and chemotherapy.

diffuse large b-cell lymphoma
hodgkin's disease
rituximab
  • 18 views
  • 07 Nov, 2020
  • 1 location